Drug Delivery

Data reported from first human study of interferon administration via AERx

Published in Hepatitis Weekly, September 2nd, 2002

Aradigm Corporation (ARDM) presented data on recombinant human interferon-alfa-2b administered by the company's AERx System, a pulmonary drug delivery platform.

The podium presentation entitled, "Evaluation of the AERx System for the Pulmonary Delivery of Recombinant Human Interferon alfa-2b to Healthy Subjects," was presented at the 29th annual meeting of the Controlled Release Society in Seoul, Korea. Data showed that the AERx Pulmonary Drug Delivery System appears to be safe, convenient, and well tolerated for the noninvasive systemic delivery of interferon alfa-2b using the inhalation route in healthy volunteers.

Interferon alfa delivered by...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2002-09-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry